- Report
- April 2024
- 185 Pages
From €4712EUR$4,900USD£4,042GBP
- Report
- October 2023
- 75 Pages
Malaysia
From €3365EUR$3,500USD£2,887GBP
- Newsletter
- May 2024
- 3 Pages
Global
From €126EUR$131USD£108GBP
- Report
- March 2019
- 96 Pages
Global
€2880EUR$2,995USD£2,470GBP
- Report
- February 2019
- 156 Pages
Global
From €2885EUR$3,000USD£2,475GBP
- Report
- November 2018
- 12 Pages
Global
From €192EUR$200USD£165GBP
- Report
- November 2018
- 125 Pages
Europe
From €2885EUR$3,000USD£2,475GBP
- Report
- March 2018
- 123 Pages
Global
From €7212EUR$7,500USD£6,187GBP
- Report
- January 2018
- 59 Pages
Global
From €2880EUR$2,995USD£2,470GBP
- Report
- March 2023
- 78 Pages
South Korea
From €957EUR$995USD£821GBP
- Report
- September 2021
- 89 Pages
India
From €1875EUR$1,950USD£1,609GBP
- Report
- November 2020
- 156 Pages
Global
From €7688EUR$7,995USD£6,595GBP
- Report
- January 2023
- 44 Pages
Global
From €1442EUR$1,500USD£1,237GBP
- Report
- April 2023
- 138 Pages
Global
€9652EUR$10,389USD£8,000GBP
- Report
- November 2022
- 57 Pages
Global
€9652EUR$10,389USD£8,000GBP
- Report
- July 2022
- 60 Pages
France
€9652EUR$10,389USD£8,000GBP
- Report
- July 2022
- 59 Pages
United Kingdom
€9652EUR$10,389USD£8,000GBP
- Report
- June 2022
- 63 Pages
Global
€7842EUR$8,441USD£6,500GBP
- Report
- June 2022
- 91 Pages
Global
€9652EUR$10,389USD£8,000GBP
- Report
- May 2022
- 64 Pages
Global
€9652EUR$10,389USD£8,000GBP
The Pharmaceutical Market Access market is a sector of the pharmaceutical industry that focuses on the commercialization of drugs and other healthcare products. It involves the development of strategies to ensure that products are available to patients and healthcare providers in a timely and cost-effective manner. This includes activities such as pricing, reimbursement, distribution, and promotion. Market access teams work to ensure that products are available to the right patients, at the right time, and at the right price.
Companies in the Pharmaceutical Market Access market include AbbVie, AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more